Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies.
Noble CW, Gangaputra SS, Thompson IA, Yuan A, Apolo AB, Lee JM, Papaliodis GN, Kodati S, Bishop R, Magone MT, Sobrin L, Sen HN.
Noble CW, et al.
Ocul Immunol Inflamm. 2020 Aug 17;28(6):854-859. doi: 10.1080/09273948.2019.1583347. Epub 2019 Apr 23.
Ocul Immunol Inflamm. 2020.
PMID: 31013173
Free PMC article.